A history of treatments for myasthenia gravis

Seminars in Neurology
John Carl Keesey

Abstract

Much of the improvement in the treatment of myasthenia gravis (MG) over the past 125 years can be attributed to the effectiveness of general medical measures such as advances in respiratory care and the discovery of antibiotics. Although MG became the model of an antibody-mediated autoimmune disease in the 1970s (the most documented antigen being the muscle acetylcholine receptor at the neuromuscular junction), the pathogenesis of MG has not been the rationale for most treatments found to be useful for this disease. The serendipitous benefit of anticholinesterases for MG in the 1930s subsequently focused attention on the neuromuscular junction. The beginnings of the controversy over thymectomy for MG in the 1940s and 1950s preceded the discovery in 1960 of the function of the thymus. Before the autoimmune pathogenesis of MG was known, adrenocorticotropic hormone (ACTH) and steroids for MG were tried for reasons that turned out to be incorrect. Further immunosuppressive treatments for MG were largely empirical, following their use in organ transplantation and other autoimmune diseases. More specific treatments, based on our knowledge of pathogenesis, are still experimental but hopefully will be the history of the future.

Citations

Jul 3, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·M OverhausN Schäfer
Oct 30, 2007·Journal of the History of the Neurosciences·John Keesey, Johan Aarli
Jul 31, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Stephanie E Matney, Danny R Huff
Nov 13, 2010·Thoracic Surgery Clinics·Karl K Limmer, Kemp H Kernstine
Jan 1, 2008·Seminars in Thoracic and Cardiovascular Surgery·Shannon L Castle, Kemp H Kernstine
Sep 17, 2013·Muscle & Nerve·Linda L KusnerHenry J Kaminski
Jul 16, 2015·Autoimmune Diseases·Fawzi AbukhalilAaron McMurtray
Aug 11, 2016·The New England Journal of Medicine·Allan H Ropper
Aug 25, 2005·Expert Review of Vaccines·Sylvia Cohen-Kaminsky, Florence Jambou
Sep 13, 2005·Current Opinion in Neurology·Angela Vincent, Maria Isabel Leite
Mar 28, 2020·Arquivos de neuro-psiquiatria·Paulo José LorenzoniRosana Herminia Scola
Apr 13, 2017·Pediatric Surgery International·Arin L MadenciChristopher B Weldon
Dec 8, 2020·Indian Journal of Surgical Oncology·Arvind KumarSrinivas Kodaganur Gopinath
Jul 7, 2021·Expert Opinion on Emerging Drugs·Deepak MenonVera Bril
Nov 22, 2020·Neurology·Robert M Feibel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.